Emily Aspasia Karanges (Emily A Karanges)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Anti Inflammatory

Health Insurance

Top Venues

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Emily Aspasia Karanges, Conrad Nangla, Lisa M Parker, Alice Fabbri, Cynthia M Farquhar, Lisa A Bero
Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study. BMJ open 11 (9) (2021)
Andrea L Schaffer, Emily Aspasia Karanges, Nicholas Alan Buckley, Andrew Wilson, Louisa Degenhardt, Briony Larance, Sallie-Anne Pearson
Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study. Pharmacoepidemiology and drug safety 28 (1) (2018)
Natasa Gisev, Sallie-Anne Pearson, Emily Aspasia Karanges, Briony Larance, Nicholas Alan Buckley, Sarah Larney, Timothy A Dobbins, Bianca Blanch, Louisa Degenhardt
To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia? Pharmacoepidemiology and drug safety 27 (5) (2017)
Emily Aspasia Karanges, Nicholas A Buckley, Jonathan Brett, Bianca Blanch, Melisa Litchfield, Louisa Degenhardt, Sallie-Anne Pearson
Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics. Pharmacoepidemiology and drug safety 27 (5) (2017)